Back to Results

A Phase 3, Open-label, Multi-center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger

Study

Is this Study for You?

Let's Get Started!

Description

? 11 visits over 27 months ? Physical Exam, Pelvic Exam, Pap smear (if needed), STI screening ? Blood draws ? Daily e-diary completion

Details
Age

Adult

Eligibility

? Age: 18-35 years ? Sexually Active ? Must have a palpable implant in place (for at least 2 years, no longer than 3 years by the time of enrollment)

Type of Study

Device Feasibility

Locations

Comprehensive Women's Health Center

Principal Investigator
Rebecca Cohen,  MD, MPH

Rebecca Cohen, MD, MPH

Study ID

Protocol Number: 20-2734

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers